The federal Project Grant award R01GM153805 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to President And Fellows Of Harvard College, Office Of Research Administration Division (doing business as Harvard Medical School). The $665,616 award supports the development of a novel micro-capsule technology to enable high-throughput screening and mapping of cell-cell interactions. This technology aims to significantly accelerate the ability to gain quantitative insights into cell-cell interactions in health and disease, and to enable new platforms for therapeutic discovery. The award began on Sep 17, 2024 and is scheduled for completion on Aug 31, 2028. As a sub-awardee, Harvard Medical School has contributed expertise in areas such as structural biology, data visualization, biostatistics, neuroethics, and healthcare policy research to support multi-institutional collaborations funded by the National Institutes of Health, Department of Defense, and Agency for Healthcare Research and Quality.
Generated 3/4/25, 8:30 AM